Ironwood Pharmaceuticals, Inc. (IRWD) return on equity (ROE)

Return on equity · fiscal 2022
26.8%

Ironwood Pharmaceuticals, Inc. (IRWD) earned a return on equity of 26.8% in fiscal 2022 (the year ended December 31, 2022). That is 60.4 percentage points lower than the 87.2% of fiscal 2021. Figures as of 18 Nov 2026, 10:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2022
26.8%
Change on fiscal 2021
−60.4 pts
Highest on record
169.5%fiscal 2020
Lowest on record
-1187.4%fiscal 2017
Fiscal years on record
92010–2022

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Ironwood Pharmaceuticals, Inc. return on equity (ROE), in more detail

Across the 9 fiscal years on record (2010–2022), the highest was 169.5% in fiscal 2020 and the lowest -1187.4% in fiscal 2017. The fiscal 2022 figure is higher than in 75% of the 8 earlier fiscal years on record, whose median is -54.7%.

History · 9 fiscal years

Return on equity by fiscal year

Ironwood Pharmaceuticals, Inc. return on equity (ROE), year by year

Ironwood Pharmaceuticals, Inc. (IRWD) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202226.8% 60.4 pts down
202187.2% 82.3 pts down
2020169.5%—
2017-1187.4% 1064.9 pts down
2016-122.5% 27.5 pts up
2015-150.0%—
2012-50.4% 8.6 pts up
2011-59.0% 26.5 pts down
2010-32.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on IRWD

Ironwood Pharmaceuticals, Inc., figure by figure

Ironwood Pharmaceuticals, Inc. (IRWD) overview: price, valuation and scorecard

Ironwood Pharmaceuticals, Inc. return on equity (ROE): questions and answers

What is Ironwood Pharmaceuticals, Inc.'s return on equity?

Ironwood Pharmaceuticals, Inc. (IRWD) earned a return on equity of 26.8% in fiscal 2022 (the year ended December 31, 2022). That is 60.4 percentage points lower than the 87.2% of fiscal 2021.

Is Ironwood Pharmaceuticals, Inc.'s return on equity high or low compared with its own history?

The fiscal 2022 figure is higher than in 75% of the 8 earlier fiscal years on record, whose median is -54.7%.

What are the highest and lowest return on equity figures on record for Ironwood Pharmaceuticals, Inc.?

Across the 9 fiscal years on record (2010–2022), the highest was 169.5% in fiscal 2020 and the lowest -1187.4% in fiscal 2017.

How is Ironwood Pharmaceuticals, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative. For Ironwood Pharmaceuticals, Inc. it is on record here for 9 fiscal years, 2010 to 2022.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.